company-logo

Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Cognetivity Neurosciences Dividend Announcement

Cognetivity Neurosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Cognetivity Neurosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Cognetivity Neurosciences Dividend History

Cognetivity Neurosciences Dividend Yield

Cognetivity Neurosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cognetivity Neurosciences stock? Use our calculator to estimate your expected dividend yield:

Cognetivity Neurosciences Financial Ratios

P/E ratio-0.09
PEG ratio0.17
P/B ratio-0.02
ROE27.85%
Payout ratio0.00%
Current ratio0.02
Quick ratio0.02
Cash Ratio0.00

Cognetivity Neurosciences Dividend FAQ

Does Cognetivity Neurosciences stock pay dividends?
Cognetivity Neurosciences does not currently pay dividends to its shareholders.
Has Cognetivity Neurosciences ever paid a dividend?
No, Cognetivity Neurosciences has no a history of paying dividends to its shareholders. Cognetivity Neurosciences is not known for its dividend payments.
Why doesn't Cognetivity Neurosciences pay dividends?
There are several potential reasons why Cognetivity Neurosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cognetivity Neurosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cognetivity Neurosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cognetivity Neurosciences a dividend aristocrat?
Cognetivity Neurosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cognetivity Neurosciences a dividend king?
Cognetivity Neurosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cognetivity Neurosciences a dividend stock?
No, Cognetivity Neurosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cognetivity Neurosciences stocks?
To buy Cognetivity Neurosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cognetivity Neurosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.